{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T08:29:27Z","timestamp":1772612967586,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The southeastern US is an epicenter for incident HIV in the US with high prevalence of human papillomavirus (HPV) co-infections. However, epidemiologies of HPV-associated clinical conditions (CC) among people living with HIV-1 infection (PLWH) are not fully known.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Electronic medical records (EMR) of PLWH attending one of the leading HIV clinics in the southeastern US between 2006 and 2018 were reviewed and analyzed. The retrospective study was nested within the University of Alabama at Birmingham HIV clinical cohort, which has electronically collected over 7000 PLWH\u2019s clinical and sociobehavioral data since 1999. Incidence rates of HPV-related CC including anogenital warts, penile, anal, cervical, and vaginal\/vulvar low- and high-grade squamous intraepithelial lesions (LSIL and HSIL) were estimated per 10,000 person years. Joinpoint regressions were performed to examine temporal changes in the trends of incident CC. All rates and trends were stratified by gender and race.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 4484 PLWH included in the study (3429 men, 1031 women, and 24 transgender), we observed 1038 patients with HPV-related CC. The median nadir CD4 count (cells\/uL) was higher in the HPV-condition free group than the case groups (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001). Anogenital warts, anal LSIL, HSIL, and cancer were more likely to be diagnosed among HIV-infected men than women. White men presented more frequently with anal LSIL and anal and penile cancers than black men (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.03). White women were also more likely to be diagnosed with cervical HSIL (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.023) and cancer (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.037) than black women.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There were significant differences between gender and race with incidence of HPV-related CC among HIV patients. EMR-based studies provide insights on understudied HPV-related anogenital conditions in PLWH; however, large-scale studies in other regions are needed to generalize current findings and draw public health attention to co-infection induced non-AIDS defining comorbidities among PLWH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-4822-5","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T12:02:42Z","timestamp":1581681762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Comorbidities associated with HPV infection among people living with HIV-1 in the southeastern US: a retrospective clinical cohort study"],"prefix":"10.1186","volume":"20","author":[{"given":"Yuanfan","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greer A.","family":"Burkholder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard W.","family":"Wiener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella","family":"Aslibekyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Fry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7002-357X","authenticated-orcid":false,"given":"Sadeep","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,14]]},"reference":[{"issue":"11","key":"4822_CR1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1080\/14787210.2017.1392854","volume":"15","author":"M Poljak","year":"2017","unstructured":"Poljak M, Sterbenc A, Lunar MM. Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV). Expert Rev Anti Infect Ther. 2017;15(11):987\u201399.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"4822_CR2","volume-title":"Human papillomavirus (HPV)","author":"Centers for Disease Control and Prevention","year":"2020","unstructured":"Centers for Disease Control and Prevention. Human papillomavirus (HPV). Atlanta: Department of Health and Human Services; 2020."},{"issue":"2","key":"4822_CR3","first-page":"F55","volume":"1288","author":"H zur Hausen","year":"1996","unstructured":"zur Hausen H. Papillomavirus Infections \u2013 a major cause of human cancers. Biochim Biophys Acta. 1996;1288(2):F55\u201378.","journal-title":"Biochim Biophys Acta"},{"key":"4822_CR4","volume-title":"Prevalence of HPV in adults aged 18\u201369: United States, 2011\u20132014. NCHS data brief, no 280","author":"G McQuillan","year":"2017","unstructured":"McQuillan G, Kruszon-Moran D, Markowitz LE, Unger ER, Paulose-Ram R. Prevalence of HPV in adults aged 18\u201369: United States, 2011\u20132014. NCHS data brief, no 280. Hyattsville: National Center for Health Statistics; 2017."},{"issue":"6","key":"4822_CR5","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/QAD.0000000000001765","volume":"32","author":"G Liu","year":"2018","unstructured":"Liu G, Sharma M, Barnabas RV. HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer. AIDS. 2018;32(6):795\u2013808.","journal-title":"AIDS"},{"issue":"12","key":"4822_CR6","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1086\/657321","volume":"202","author":"Laia Bruni","year":"2010","unstructured":"Bruni L, Diaz M, Castellsagu\u00e9 X, Ferrer E, Bosch FX, de Sanjos\u00e9 S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010; 202:1789\u201399.","journal-title":"The Journal of Infectious Diseases"},{"issue":"9","key":"4822_CR7","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/cid\/cix135","volume":"64","author":"Gary M. Clifford","year":"2017","unstructured":"Clifford GM, Tully S, Franceschi S. Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis from HPV Infection to Cervical Cancer Clinical Infectious Diseases. 2017;1228\u201335.","journal-title":"Clinical Infectious Diseases"},{"issue":"11","key":"4822_CR8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/jnci\/93.11.843","volume":"93","author":"E. A. Holly","year":"2001","unstructured":"Holly EA, Ralston ML, Darragh TM, Greenblatt RM, Jay N, Palefsky JM. Prevalence and Risk Factors for Anal Squamous Intraepithelial Lesions in Women. JNCI Journal of the National Cancer Institute. 2001;93:843\u20139.","journal-title":"JNCI Journal of the National Cancer Institute"},{"issue":"4","key":"4822_CR9","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/00042560-199804010-00004","volume":"17","author":"Joel M. Palefsky","year":"1998","unstructured":"Palefsky JM, Holly EA, Hogeboom CJ, Ralston ML, DaCosta MM, Botts R, et al. Virologic, Immunologic, and Clinical Parameters in the Incidence and Progression of Anal Squamous Intraepithelial Lesions in HIV-Positive and HIV-Negative Homosexual Men. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;17:314\u20139.","journal-title":"Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology"},{"issue":"5","key":"4822_CR10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/00002030-199805000-00011","volume":"12","author":"Joel M. Palefsky","year":"1998","unstructured":"Palefsky JM, Holly EA, Ralston ML, Jay N, Michael Berry J, Darragh TM. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS. 1998;12:495\u2013503.","journal-title":"AIDS"},{"issue":"6","key":"4822_CR11","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"Nubia Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz N, Bosch FX, de Sanjos\u00e9 S, Herrero R, Castellsagu\u00e9 X, Shah KV, Snijders PJ, Meijer CJ. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. New Engl J Med. 2003;348(6):518\u201327.","journal-title":"New England Journal of Medicine"},{"key":"4822_CR12","doi-asserted-by":"crossref","unstructured":"Schiffman M, Wentzensen N. Human papillomavirus (HPV) infection and the multi-stage carcinogenesis of cervical cancer. Schiffman M, Wentzensen N. Human papillomavirus infection and the multistage carcinogenesis of cervical cancer. Cancer Epidemiol Biomarkers Prev. 2013;22(4):553\u201360.","DOI":"10.1158\/1055-9965.EPI-12-1406"},{"key":"4822_CR13","doi-asserted-by":"crossref","unstructured":"Ram\u00edrez-Fort MK, Khan F, Rady PL, Tyring SK. Human Papillomavirus: Bench to Bedside. Curr Probl Dermatol. Basel, Karger, 2014, vol 45, pp I-VIII","DOI":"10.1159\/isbn.978-3-318-02527-9"},{"key":"4822_CR14","doi-asserted-by":"crossref","unstructured":"Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu Cw, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, Copeland G, Cozen W, Peters ES, Huang Y, Saber MS, Altekruse S, Goodman MT, HPV Typing of Cancers Workgroup. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 2015;107(6):djv086.","DOI":"10.1093\/jnci\/djv086"},{"key":"4822_CR15","unstructured":"Quaterly Report. Alabama Department of Public Health. Division of STI\/HIV Prevention and Control. (https:\/\/www.alabamapublichealth.gov\/hiv\/index.html) Accessed 10 Jan 2020."},{"issue":"12","key":"4822_CR16","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1089\/aid.2010.0059","volume":"26","author":"James H. Willig","year":"2010","unstructured":"Willig JH, Aban I, Nevin CR, Ye J, Raper JL, McKinnel JA, Delaitsch LL, Mrus JM, De La Rosa GR, Mugavero MJ, Saag MS. Darunavir outcomes study: Comparative effectiveness of virologic suppression, regimen durability, and discontinuation reasons for three-class experienced patients at 48 weeks. AIDS Res Hum Retroviruses. 2010;26:1279\u201385.","journal-title":"AIDS Research and Human Retroviruses"},{"key":"4822_CR17","unstructured":"National Cancer Institute. Joinpoint Regression Program. Version 4.3.1.0. The Institute; 2016."},{"issue":"3","key":"4822_CR18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"Hyune-Ju Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune, DN. Permutation Tests for Joinpoint Regression with Applications to Cancer Rates\", Statistics in Medicine 19. 2000;335\u201351.","journal-title":"Statistics in Medicine"},{"issue":"29","key":"4822_CR19","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1002\/sim.3733","volume":"28","author":"Limin X. Clegg","year":"2009","unstructured":"Clegg L, Hankey B, Tiwari R, Feuer E, Edwards B. Estimating average annual percent change in trend analysis. Stat Med. 2009;28(29):3670\u20138.","journal-title":"Statistics in Medicine"},{"issue":"19","key":"4822_CR20","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1002\/sim.7344","volume":"36","author":"Hyune-Ju Kim","year":"2017","unstructured":"Kim HJ,  Luo J, Chen HS, Green D, Buckman D, Byrne J, Feuer EJ. Improved confidence interval for average annual percent change in trend analysis. Statistics in medicine vol. 36, 19 (2017): 3059\u201374.","journal-title":"Statistics in Medicine"},{"issue":"4","key":"4822_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.currproblcancer.2012.03.007","volume":"36","author":"Henry S. Park","year":"2012","unstructured":"Park HS, Lloyd S, Decker RH, Wilson LD, Yu JB. Overview of the Surveillance, Epidemiology, and End Results database: evolution, data variables, and quality assurance. Curr Probl Cancer. 2012;36:183\u2013190.","journal-title":"Current Problems in Cancer"},{"issue":"4","key":"4822_CR22","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.jadohealth.2010.01.010","volume":"46","author":"Joel M. Palefsky","year":"2010","unstructured":"Palefsky JM. Human Papillomavirus-Related Disease in Men: Not Just a Women\u2019s Issue. Journal of Adolescent Health. 2010;46:S12\u20139.","journal-title":"Journal of Adolescent Health"},{"key":"4822_CR23","unstructured":"Health Resources and Services Administration (HRSA), US Department of Health and Human Services. HIV\/AIDS Bureau Performance Measures \u2013 Cervical Cancer Screening. https:\/\/hab.hrsa.gov\/sites\/default\/files\/hab\/About\/clinical-quality-management\/adolescentadultmeasures.pdf. Accessed 10 Jan 2020."},{"issue":"3","key":"4822_CR24","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s11904-014-0224-x","volume":"11","author":"Maarten F. Schim van der Loeff","year":"2014","unstructured":"Schim van der Loeff MF, Mooij SH, Richel O, de Vries HJC, Prins JM. HPV and anal cancer in HIV-infected individuals: a review. Curr HIV\/AIDS Rep. 2014;11:250\u201362.","journal-title":"Current HIV\/AIDS Reports"},{"key":"4822_CR25","doi-asserted-by":"crossref","unstructured":"D\u2019Souza G, Wiley DJ, Li X, Chmiel JS, Margolick JB, Cranston RD, et al. Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr. 2008;48:491\u20139.","DOI":"10.1097\/QAI.0b013e31817aebfe"},{"issue":"S3","key":"4822_CR26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s10461-019-02659-6","volume":"23","author":"Meg Watson","year":"2019","unstructured":"Watson M, Johnson SD, Zhang T, Oster AM. Characteristics of and Trends in HIV Diagnoses in the Deep South Region of the United States, 2012-2017. AIDS Behav. 2019;23(Suppl 3):224\u201332.","journal-title":"AIDS and Behavior"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-4822-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-4822-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-4822-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T14:35:04Z","timestamp":1613226904000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-4822-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,14]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4822"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-4822-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.13654\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.13654\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,14]]},"assertion":[{"value":"15 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the UAB Institutional Review Board for Human Use (IRB-170329001), and performed in accordance with the ethical guidelines of the Declaration of Helsinki. Animals were not used in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not Applicable. No individual data or image is presented. All results are presented as aggregate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"144"}}